검색어 : 통합검색[338.1]
총 4,033건 중 1,000건 출력
, 8/100 페이지
-
71
- 338. METHYL BINDING DOMAIN PROTEIN (MBD1) IN THE NUCLEUS OF THE MOUSE ZYGOTE
- Li, Y.; Jin, X. L.; O'Neill, C.; ; (Reproduction, fertility, and development, v.22, 2010, pp.138)
-
72
- TUC338 promotes cell migration and invasion by targeting TIMP1 in cervical cancer
- Li, Qin; Shen, Feiyang; Wang, Chenghai; ; (Oncology letters, v.13, 2017, pp.4526-4532)
-
73
- Hsa_circFOXP1 Contributes to Breast Cancer Progression through Regulating miR-338-3p
- Wu, Kaiding; Cheng, Kunkun; First Clinical Medical College, Nanjing Medical University, 210009 Nanjing, Jiangsu, China; Department of Nursing, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The Affiliated Cancer Hospital of Nanjing Medical University, 210009 Nanjing, Jiangsu, China; (Clinical and experimental obstetrics & gynecology, v.51, 2024, pp.112)
-
74
- miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1
- Liu, Chunxi; Wang, Zhiyu; Wang, Yi; Gu, Wuwei; ; (Molecular and cellular biochemistry, v.398, 2015, pp.115-122)
-
75
- Lnc-HSD17B11-1:1 Functions as a Competing Endogenous RNA to Promote Colorectal Cancer Progression by Sponging miR-338-3p to Upregulate MACC1
- Zhang, Wei; Wang, Bo; Wang, Quan; Zhang, Zhen; Shen, Zhanlong; Ye, Yingjiang; Jiang, Kewei; Wang, Shan; Department of Gastroenterological Surgery, Peking University People’s Hospital , Beijing , China; Department of Gastroenterological Surgery, Peking University People’s Hospital , Beijing , China; Laboratory of Surgical Oncology, Peking University People’s Hospital , Beijing , China; Department of Gastroenterological Surgery, Peking University People’s Hospital , Beijing , China; Department of Gastroenterological Surgery, Peking University People’s Hospital , Beijing , China; Department of Gastroenterological Surgery, Peking University People’s Hospital , Beijing , China; Department of Gastroenterological Surgery, Peking University People’s Hospital , Beijing , China; Laboratory of Surgical Oncology, Peking University People’s Hospital , Beijing , China; (Frontiers in genetics, v.11, 2020, pp.628)
-
76
- 1P338 Mechanical responses of single living cell to elongation and contraction : Development of a measuring system using SPM
- Tamura, K.; Mizutani, T.; Haga, H.; Kawabata, K.; ; (生物物理 = Biophysics, v.45, 2005, pp.S116)
-
77
- MiRNA-338-3p inhibit neuroinflammation in the corpus callosum of ICV-LPS rats via STAT1 signal pathway
- Liu Nan; Zhou Qiuping; Wang Huifang; Li Qian; Chen Zhuo; Lin Yiyan; Yi Lingling; Jiang Shuqi; Chen Chunbo; Deng Yiyu.; South China University of Technology; South China University of Technology; Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University; Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University; South China University of Technology; Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University; South China University of Technology; Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University; South China University of Technology; South China University of Technology; (, v., 2023, )
-
78
- circRAE1 promotes colorectal cancer cell migration and invasion through modulating miR-338-3p/TYRO3 axis
- Du Jiabin; Xu Jianhua; Chen Junxing; Liu Weinan; Wang Pengcheng; Ye kai; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; (, v., 2020, )
-
79
- miR‑338‑3p regulates the proliferation, apoptosis and migration of SW480 cells by targeting MACC1
- Lu Mingliang; Huang Hua; Yang Jinhui; Li Jun; Zhao Gongfang; Li Weihua; Li Xinhua; Liu Guobin; Wei Li; Shi Baoping; Zhao Chunping; Fu Yan; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; Department of Gastroenterology, No. 1 People' s Hospital of Dali City, Dali, Yunnan 671000, P.R. China; Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; (Experimental and Therapeutic Medicine, v., 2019, )
-
80
- Circ_0055625 knockdown inhibits tumorigenesis and improves radiosensitivity by regulating miR-338-3p/MSI1 axis in colon cancer
- Gao, Chao; Zhang, Yi; Tian, Yanming; Han, Chun; Wang, Lan; Ding, Boyue; Tian, Hua; Zhou, Chaoxi; Ju, Yingchao; Peng, Ale; Yu, Qiyao; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Department of Physiology, Hebei Medical University, Shijiazhuang, 050011 Hebei Province China; Department of Physiology, Hebei Medical University, Shijiazhuang, 050011 Hebei Province China; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Department of Experimental Animal Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical Unive; (World journal of surgical oncology, v.19, 2021, pp.131)
QUICK MENU
